Bélgica - alemán - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

msd belgium - pneumokokken-polysaccharid-impfstoff, 23-valent - injektionslösung in einer fertigspritze - pneumokokken-polysaccharid-impfstoff, 23-valent - pneumococcal vaccines

Unión Europea - alemán - EMA (European Medicines Agency)

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumokokkeninfektionen - impfstoffe - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. siehe abschnitte 4. 4 und 5. 1 für informationen zum schutz gegen spezifische pneumokokken-serotypen. apexxnar should be used in accordance with official recommendations. .

Suiza - alemán - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

msd animal health gmbh - clostridium (c.) perfringens, type c (strains 554 and 578), beta-toxoid, induced, clostridium (c.) perfringens, type d, epsilon toxoid, induced, clostridium (c.) septicum toxoid, induced, clostridium (c.) tetani toxoid, induced, clostridium (c.) novyi, type b, toxoid, induced, inactivated germs of clostridium (c.) chauvoei (strains 655, 656, 657, 658 and 1048) & equivalent toxoid, induced, inactivated germs of mannheimia haemolytica of serotypes a1, a2, a6, a7, a9, inactivated germs of pasteurella trehalosi of serotypes t3, t4, t10, t15 - injektionssuspension für schafe und ziegen - clostridium (c.) perfringens, type c (strains 554 and 578), beta-toxoid, induced ≥ 10.0 u., clostridium (c.) perfringens, type d, epsilon toxoid, induced ≥ 5.0 u., clostridium (c.) septicum toxoid, induced ≥ 2.5 u., clostridium (c.) tetani toxoid, induced ≥ 2.5 u., clostridium (c.) novyi, type b, toxoid, induced ≥ 3.5 u., inactivated germs of clostridium (c.) chauvoei (strains 655, 656, 657, 658 and 1048) & equivalent toxoid, induced ≥ 1.0 u., inactivated germs of mannheimia haemolytica of serotypes a1, a2, a6, a7, a9 je 1 x 10^9 u., inactivated germs of pasteurella trehalosi of serotypes t3, t4, t10, t15 je 1 x 10^9 u., aluminii oxidum hydricum 800 mg, thiomersalum 0.134-0.3 mg, formaldehydum < 0.5 mg/ml, trometamolum, acidum maleicum, natrii chloridum, aqua ad iniectabile, ad suspensionem pro dosi 2 ml. - inaktivierter bakterieller impfstoff gegen clostridien, mannheimia haemolytica und pasteurella trehalosi bei schafen und ziegen - impfstoffe

Alemania - alemán - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

acis arzneimittel gmbh (8087957) - dexamethasondihydrogenphosphat-dinatrium (ph.eur.) - injektionslösung - teil 1 - injektionslösung; dexamethasondihydrogenphosphat-dinatrium (ph.eur.) (02114) 8,744 milligramm

Alemania - alemán - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

merck healthcare germany gmbh (8128716) - dexamethasondihydrogenphosphat-dinatrium (ph.eur.) - injektionslösung - teil 1 - injektionslösung; dexamethasondihydrogenphosphat-dinatrium (ph.eur.) (02114) 4,37 milligramm

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

lagap sa - doxycyclinum - kapseln - doxycyclinum 100 mg ut doxycyclini hyclas, maydis amylum, lactosum monohydricum 65 mg, talcum, magnesii stearas, materiale di capsula: gelatina, e 132, e 171, e 172 (flavum), aqua purificata, tinta: lacca, e 171, alcohol isopropylicus, alcohol butylicus, propylenglycolum, pro capsula. - infektionskrankheiten - synthetika

Austria - alemán - AGES (Agentur für Gesundheit und Ernährungssicherheit)

piramal critical care b.v. - sevofluran -

Alemania - alemán - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

piramal critical care b.v. (8185275) - sevofluran - flüssigkeit zur herstellung eines dampfs zur inhalation - sevofluran (26960) information nicht vorhanden

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - methylphenidati hydrochloridum - equasym xr 10 mg; retardkapseln - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum 34.1-49.5 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhs - synthetika

Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - methylphenidati hydrochloridum - equasym xr 20 mg; retardkapseln - methylphenidati hydrochloridum 20 mg, sacchari sphaerae corresp. saccharum 68.2-99.7 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhs - synthetika